Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-09-08 Purchase |
2021-09-10 4:57 pm |
LUMOS PHARMA INC. | LUMO | LALANDE KEVIN M. Director |
10,000 | $11.21 | $112,116 | 731,522 (Indirect Direct) |
View |
2021-09-02 Purchase |
2021-09-07 5:56 pm |
LUMOS PHARMA INC. | LUMO | LALANDE KEVIN M. Director |
24,400 | $11.22 | $273,783 | 721,522 (Indirect Direct) |
View |
2021-08-30 Purchase |
2021-09-01 6:46 pm |
LUMOS PHARMA INC. | LUMO | LALANDE KEVIN M. Director |
19,214 | $10.66 | $204,811 | 697,122 (Indirect Direct) |
View |
2021-08-25 Purchase |
2021-08-27 7:16 pm |
LUMOS PHARMA INC. | LUMO | LALANDE KEVIN M. Director |
26,081 | $10.04 | $261,790 | 678,908 (Indirect Direct) |
View |
2021-08-20 Purchase |
2021-08-24 6:19 pm |
LUMOS PHARMA INC. | LUMO | LALANDE KEVIN M. Director |
84,254 | $9.2062 | $775,660 | 652,827 (Indirect Direct) |
View |
2021-08-17 Purchase |
2021-08-19 8:14 pm |
LUMOS PHARMA INC. | LUMO | LALANDE KEVIN M. Director |
64,870 | $8.5775 | $556,426 | 568,573 (Indirect Direct) |
View |
2021-08-12 Purchase |
2021-08-16 6:09 pm |
LUMOS PHARMA INC. | LUMO | LALANDE KEVIN M. Director |
93,000 | $7.7892 | $724,393 | 503,703 (Indirect Direct) |
View |
2021-08-11 Purchase |
2021-08-13 4:32 pm |
LUMOS PHARMA INC. | LUMO | Schuchart Aaron Chief Business Officer |
2,000 | $7.4095 | $14,819 | 3,037 (Direct) |
View |
2021-08-11 Purchase |
2021-08-13 4:31 pm |
LUMOS PHARMA INC. | LUMO | McCracken Joseph S Director |
7,475 | $7.546 | $56,406 | 8,551 (Direct) |
View |
2021-01-06 Sale |
2021-01-08 5:54 pm |
LUMOS PHARMA INC. | LUMO | Flynn James E Deerfield Mgmt III L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Private Design Fund III L.P. *Possible Member of 10% Group 10% Owner |
151,723 | $22.58 | $3,425,623 | 784,568 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-09-02 6:39 pm |
N/A N/A |
LUMOS PHARMA INC. | LUMO | Karpf David B Chief Medical Officer |
0 | $0 | 50,000 (Direct) |
View |
2021-08-01 Option Award |
2021-08-03 6:09 pm |
N/A N/A |
LUMOS PHARMA INC. | LUMO | McKew John C. Chief Scientific Officer |
20,000 | $0 | 33,226 (Direct) |
View |
2021-08-01 Option Award |
2021-08-03 6:09 pm |
N/A 2031-07-31 |
LUMOS PHARMA INC. | LUMO | Lawley Lori D Chief Financial Officer |
25,000 | $0 | 30,437 (Direct) |
View |
2021-06-01 Option Award |
2021-06-03 4:52 pm |
N/A 2031-05-31 |
LUMOS PHARMA INC. | LUMO | Schuchart Aaron Chief Business Officer |
7,805 | $0 | 7,805 (Direct) |
View |
Ownership |
2021-05-28 7:03 pm |
N/A N/A |
LUMOS PHARMA INC. | LUMO | Schuchart Aaron Chief Business Officer |
0 | $0 | 54,428 (Direct) |
View |
2021-05-20 Option Award |
2021-05-24 6:37 pm |
N/A 2031-05-19 |
LUMOS PHARMA INC. | LUMO | Zoth Lota S. Director |
3,277 | $0 | 5,097 (Direct) |
View |
2021-05-20 Option Award |
2021-05-24 6:37 pm |
N/A 2031-05-19 |
LUMOS PHARMA INC. | LUMO | van Es-Johansson An Director |
3,277 | $0 | 4,010 (Direct) |
View |
2021-05-20 Option Award |
2021-05-24 6:36 pm |
N/A 2031-05-19 |
LUMOS PHARMA INC. | LUMO | Raffin Thomas A. Director |
3,277 | $0 | 11,166 (Direct) |
View |
2021-05-20 Option Award |
2021-05-24 6:36 pm |
N/A 2031-05-19 |
LUMOS PHARMA INC. | LUMO | McCracken Joseph S Director |
3,277 | $0 | 3,986 (Direct) |
View |
2021-05-20 Option Award |
2021-05-24 6:36 pm |
N/A 2031-05-19 |
LUMOS PHARMA INC. | LUMO | LALANDE KEVIN M. Director |
3,277 | $0 | 413,613 (Direct) |
View |
2021-05-20 Option Award |
2021-05-24 6:35 pm |
N/A 2031-05-19 |
LUMOS PHARMA INC. | LUMO | JOHNSON CHAD ALLEN Director |
3,277 | $0 | 3,986 (Direct) |
View |
2021-04-01 Tax Withholding |
2021-04-05 5:52 pm |
N/A N/A |
LUMOS PHARMA INC. | LUMO | POWERS BRADLEY J General Counsel |
342 | $12.25 | 5,109 (Direct) |
View |
2021-04-01 Tax Withholding |
2021-04-05 5:50 pm |
N/A N/A |
LUMOS PHARMA INC. | LUMO | McKew John C. Chief Scientific Officer |
1,036 | $12.25 | 13,226 (Direct) |
View |
2021-04-01 Tax Withholding |
2021-04-05 5:49 pm |
N/A N/A |
LUMOS PHARMA INC. | LUMO | Lawley Lori D Principal Accounting Officer |
274 | $12.25 | 5,437 (Direct) |
View |
2021-04-01 Tax Withholding |
2021-04-05 5:47 pm |
N/A N/A |
LUMOS PHARMA INC. | LUMO | Langren Carl W. Chief Financial Officer |
683 | $12.25 | 17,015 (Direct) |
View |
2021-04-01 Tax Withholding |
2021-04-05 5:45 pm |
N/A N/A |
LUMOS PHARMA INC. | LUMO | Hawkins Richard J Chief Executive Officer |
1,522 | $12.25 | 745,382 (Direct) |
View |
Ownership |
2021-02-18 4:22 pm |
N/A N/A |
LUMOS PHARMA INC. | LUMO | van Es-Johansson An Director |
0 | $0 | 6,462 (Direct) |
View |
2021-02-01 Option Award |
2021-02-03 6:52 pm |
N/A 2031-01-31 |
LUMOS PHARMA INC. | LUMO | POWERS BRADLEY J General Counsel |
11,494 | $0 | 16,076 (Direct) |
View |
2021-02-01 Option Award |
2021-02-03 6:52 pm |
N/A 2031-01-31 |
LUMOS PHARMA INC. | LUMO | McKew John C. Chief Scientific Officer |
34,253 | $0 | 47,437 (Direct) |
View |
2021-02-01 Option Award |
2021-02-03 6:52 pm |
N/A 2031-01-31 |
LUMOS PHARMA INC. | LUMO | Lawley Lori D Principal Accounting Officer |
11,494 | $0 | 16,336 (Direct) |
View |
2021-02-01 Option Award |
2021-02-03 6:51 pm |
N/A 2031-01-31 |
LUMOS PHARMA INC. | LUMO | Langren Carl W. Chief Financial Officer |
12,414 | $0 | 29,173 (Direct) |
View |
2021-02-01 Option Award |
2021-02-03 6:51 pm |
N/A 2031-01-31 |
LUMOS PHARMA INC. | LUMO | Kennedy Eugene P. Chief Medical Officer |
32,414 | $0 | 42,898 (Direct) |
View |
2021-02-01 Option Award |
2021-02-03 6:51 pm |
N/A 2031-01-31 |
LUMOS PHARMA INC. | LUMO | Hawkins Richard J Chief Executive Officer |
30,804 | $0 | 775,379 (Direct) |
View |